Klinik Announces Receipt of Conditional Approval for its Qualifying Transaction

Klinik also announces filing of the Filing Statement

TORONTO, June 2, 2020 /CNW/ - Klinik Health Ventures Corp. (TSXV: KHV.P) ("Klinik" or the "Corporation") is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the "Exchange") for its previously announced Qualifying Transaction (as defined under Exchange Policy 2.4) (the "Transaction") with 2576560 Ontario Inc. doing business as NeuPath Health ("NeuPath").The Transaction is expected to close on or around June 25, 2020.

Completion of the Transaction is subject to the satisfaction of conditions precedent, including without limitation, the approval of the Transaction, completed by way of plan of arrangement, by NeuPath shareholders; the approval by Klinik shareholders of matters in relation to the Transaction; and the receipt of all required consents, waivers and approvals from the Exchange and the court under the arrangement agreement governing the Transaction.

In connection with the Transaction, the Corporation has filed a filing statement (the "Filing Statement") with the Exchange, which is available on SEDAR. Additional information in respect of the Transaction can be found in the Filing Statement and the press releases dated March 20 and April 24, 2020 which are available under the Corporation's profile at www.sedar.com.

Cautionary Statement Regarding Forward-Looking Information

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.

This news release contains certain forward-looking statements, including statements relating to the completion of the Transaction and the timing for its completion; the satisfaction of closing conditions and other statements that are not historical facts. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.

Forward-looking statements involve significant risk, uncertainties and assumptions, including those described in the Filing Statement. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. As a result, the Corporation cannot guarantee that the Transaction will be completed on the terms described in the Filing Statement or at all. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Corporation cannot assure readers that actual results will be consistent with these forward-looking statements.

These forward-looking statements are made as of the date of this press release, and the Corporation assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

SOURCE Klinik Health Ventures Corp.

Klinik Health Ventures Corp., Eva Koci, Chief Executive Officer, [phone]